Latest Breast Updates from ECCO 2009

posted Sep 28 2009
We would like to thank Dr Sunil Verma for the latest ECCO Conference updates

A Phase III, randomized, double-blind study of denosumab compared with zoledronic acid in the treatment of patients with bone metastases from breast cancer

SOLTI-0701, a randomized Phase IIb trial evaluating the efficacy and safety of sorafenib in combination with capecitabine for the treatment of patients with locally advanced or metastatic breast cancer